Association of Serum Adiponectin Levels with Breast Cancer Risk

Clinical Cancer Research

Volumn 9, Issue 15, 2003, Pages 5699-5704

  Miyoshi, Yasuo ^a   Funahashi, Tohru ^a   Kihara, Shinji ^a   Taguchi, Tetsuya ^a   Tamaki, Yasuhiro ^a   Matsuzawa, Yuji ^a   Noguchi, Shinzaburo ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER RISK; CANCER SIZE; CASE CONTROL STUDY; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOLOGY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; OBESITY; PHENOTYPE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

ADIPONECTIN; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; OBESITY; PARITY; POSTMENOPAUSE; PREMENOPAUSE; PROTEINS; REFERENCE VALUES; RISK ASSESSMENT; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0345060444     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Morimoto, L. M., White, E., Chen, Z., Chlebowski, R. T., Hays, J., Kuller, L., Lopez, A. M., Manson, J., Margolis, K. L., Muti, P. C., Stefanick, M. L., and McTiernan, A. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control, 13: 741-751, 2002.
2. Hirose, K., Tajima, K., Hamajima, N., Takezaki, T., Inoue, M., Kuroishi, T., Miura, S., and Tokudome, S. Association of family history and other risk factors with breast cancer risk among Japanese premenopausal and postmenopausal women. Cancer Causes Control, 12: 349-358, 2001.
3. Tung, H. T., Tsukuma, H., Tanaka, H., Kinoshita, N., Koyama, Y., Ajiki, W., Oshima, A., and Koyama, H. Risk factors for breast cancer in Japan, with special attention to anthropometric measurements and reproductive history. Jpn. J. Clin. Oncol., 29: 137-146, 1999.
4. Edman, C. D., Aiman, E. J., Porter, J. C., and MacDonald, P. C. Identification of the estrogen product of extraglandular aromatization of plasma androstenedione. Am. J. Obstet. Gynecol., 130: 439-447, 1978.
5. Verkasalo, P. K., Thomas, H. V., Appleby, P. N., Davey, G. K., and Key, T. J. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control, 12: 47-59, 2001.
6. Bird, C. E., Cook, S., Owen, S., Sterns, E. E., and Clark, A. F. Plasma concentrations of C-19 steroids, estrogens, FSH, LH and prolactin in post-menopausal women with and without breast cancer. Oncology, 38: 365-368, 1981.
7. Moore, J. W., Clark, G. M., Bulbrook, R. D., Hayward, J. L., Murai, J. T., Hammond, G. L., and Siiteri, P. K. Serum concentrations of total and non-protein-bound oestradiol in patients with breast cancer and in normal controls. Int. J. Cancer, 29: 17-21, 1982.
8. Bernstein, L., Ross, R. K., Pike, M. C., Brown, J. B., and Henderson, B. E. Hormone levels in older women: a study of post-menopausal breast cancer patients and healthy population controls. Br. J. Cancer, 61: 298-302, 1990.
9. Toniolo, P. G., Levitz, M., Zeleniuch-Jacquotte, A., Banerjee, S., Koenig, K. L., Shore, R. E., Strax, P., and Pasternack, B. S. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J. Natl. Cancer Inst., 87: 190-197, 1995.
10. Thomas, H. V., Key, T. J., Allen, D. S., Moore, J. W., Dowsett, M., Fentiman, I. S., and Wang, D. Y. A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey. Br. J. Cancer, 76: 401-405, 1997.
11. Hankinson, S. E., Willett, W. C., Manson, J. E., Colditz, G. A., Hunter, D. J., Spiegelman, D. Barbieri, R. L., and Speizer, F. E. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J. Natl. Cancer Inst., 90: 1292-1299, 1998.
12. Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., and Matsubara, K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem. Biophys. Res. Commun., 221: 286-289, 1996.
13. Nakano, Y., Tobe, T., Choi-Miura, N. H., Mazda, T., and Tomita, M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J. Biochem. (Tokyo), 120: 803-812, 1996.
14. Yokota, T., Oritani, K., Takahashi, I., Ishikawa, J., Matsuyama, A., Ouchi, N., Kihara, S., Funahashi, T., Tenner, A. J., Tomiyama, Y., and Matsuzawa, Y. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood, 96: 1723-1732, 2000.
15. Arita, Y., Kihara, S., Ouchi, N., Maeda, K., Kuriyama, H., Okamoto, Y., Kumada, M., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., Shimomura, I., Muraguchi, M., Ohmoto, Y., Funahashi, T., and Matsuzawa, Y. Adipocyte-derived plasma protein, adiponectin, acts as a platelets growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation, 105: 2893-2898, 2002.
16. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., Ezaki, O., Akanuma, Y., Gavrilova, O., Vinson, C., Reitman, M. L., Kagechika, H., Shudo, K., Yoda, M., Nakano, Y., Tobe, K., Nagai, R., Kimura, S., Tomita, M., Froguel, P., and Kadowaki, T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med., 7: 941-946, 2001.
17. Fruebis, J., Tsao, T. S., Javorschi, S., Ebbets-Reed, D., Erickson, M. R., Yen, F. T., Bihain, B. E., and Lodish, H. F. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. USA, 98: 2005-2010, 2001.
18. Berg, A. H., Combs, T. P., Du, X., Brownlee, M., and Scherer, P. E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med., 7: 947-953, 2001.
19. Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., Komuro, R., Ouchi, N., Kihara, S., Tochino, Y., Okutomi, K., Horie, M., Takeda, S., Aoyama, T., Funahashi, T., and Matsuzawa, Y. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med., 8: 731-737, 2002.
20. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., Kuriyama, H., Nishida, M., Yamashita, S., Okubo, K., Matsubara, K., Muraguchi, M., Ohmoto, Y., Funahashi, T., and Matsuzawa, Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun., 257: 79-83, 1999.
21. Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., Nishida, M., Kihara, S., Sakai, N., Nakajima, T., Hasegawa, K., Muraguchi, M., Ohmoto, Y., Nakamura, T., Yamashita, S., Hanafusa, T., and Matsuzawa, Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol., 20: 1595-1599, 2000.
22. Yang, W. S., Lee, W. J., Funahashi, T., Tanaka, S., Matsuzawa, Y., Chao, C. L., Chen, C. L., Tai, T. Y., and Chuang, L. M. Plasma adiponectin levels in overweight and obese Asians. Obes. Res., 10: 1104-1110, 2002.
23. Hu, Y. H., Nagata, C., Shimizu, H., Kaneda, N., Kashiki, Y. Association of body mass index, physical activity, and reproductive histories with breast cancer: a case-control study in Gifu, Japan. Breast Cancer Res. Treat., 43: 65-72, 1997.
24. Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., Daly, M., Wieand, S., Tan-Chiu, E., Ford, L., and Wolmark, N. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer Inst., 90: 1371-1388, 1998.
25. Gail, M. H., Costantino, J. P., Bryant, J., Croyle, R., Freedman, L., Helzlsouer, K., and Vogel, V. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J. Natl. Cancer Inst., 91: 1829-1846, 1999.
26. Okumura, M., Yamamoto, M., Sakuma, H., Kojima, T., Maruyama, T., Jamali, M., Cooper, D., and Yasuda, K. Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-α and PPAR expression. Biochim. Biophys. Acta, 1592: 107-116, 2002.
27. Yokota, T., Oritani, K., Takahashi, I., Ishikawa, J., Matsuyama, A., Ouchi, N., Kihara, S., Funahashi, T., Tenner, A. J., Tomiyama, Y., and Matsuzawa, Y. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood, 96: 1723-1732, 2000.
28. Daling, J. R., Malone, K. E., Doody, D. R., Johnson, L. G., Gralow, J. R., and Porter, P. L. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer (Phila.), 92: 720-729, 2001.
29. Petrelli, J. M., Calle, E. E., Rodriguez, C., and Thun, M. J. Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women. Cancer Causes Control, 13: 325-332, 2002.
30. Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., and Bauer, T. L. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med., 334: 292-295, 1996.
31. McGregor, G. P., Desaga, J. F., Ehlenz, K., Fischer, A., Heese, F., Hegele, A., Lammer, C., Peiser, C., and Lang, R. E. Radiommunological measurement of leptin in plasma of obese and diabetic human subjects. Endocrinology, 137: 1501-1504, 1996.
32. Sinha, M. K., Opentanova, I., Ohannesian, J. P., Kolaczynski, J. W., Heiman, M. L., Hale, J., Becker, G. W., Bowsher, R. R., Stephens, T. W., and Caro, J. F. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J. Clin. Invest., 98: 1277-1282, 1996.
33. Dieudonne, M. N., Machinal-Quelin, F., Serazin-Leroy, V., Leneveu, M. C., Pecquery, R., and Giudicelli, Y. Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem. Biophys. Res. Commun., 293: 622-628, 2002.
34. Hu, X., Juneja, S. C., Maihle, N. J., and Cleary, M. P. Leptin - a growth factor in normal and malignant breast cells and for normal mammary gland development. J. Natl. Cancer Inst., 94: 1704-1711, 2002.
35. Tessitore, L., Vizio, B., Jenkins, O., De Stefano, I., Ritossa, C., Argiles, J. M., Benedetto, C., and Mussa, A. Leptin expression in colorectal and breast cancer patients. Int. J. Mol. Med., 5: 421-426, 2000.
36. Mantzoros, C. S., Bolhke, K., Moschos, S., and Cramer, D. W. Leptin in relation to carcinoma in situ of the breast: a study of premenopausal cases and controls. Int. J. Cancer, 80: 523-526, 1999.
37. Petridou, E., Papadiamantis, Y., Markopoulos, C., Spanos, E., Dessypris, N., and Trichopoulos, D. Leptin and insulin growth factor 1 in relation to breast cancer (Greece). Cancer Causes Control, 11: 383-388, 2000.